上海醫藥(601607.SH)：I040獲得臨牀試驗批准通知書

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

上海醫藥(601607.SH)：I040獲得臨牀試驗批准通知書

格隆匯 05-24 18:00

格隆匯5月24日丨上海醫藥(601607.SH)公佈，公司開發的“I040”(稱“該項目”)臨牀試驗申請收到國家藥品監督管理局核准簽發的《藥物臨牀試驗批准通知書》。I040是一款小分子化合物，臨牀前研究顯示I040能在多個抑鬱症動物模型上起到改善核心症狀的效果，且安全性較佳。

上海醫藥(02607.HK)

Relevant Stocks

上海醫藥(02607.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

上海醫藥(601607.SH)：I040獲得臨牀試驗批准通知書

Services

About Us

Agreement Statement